Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 11/20 | 0.56 |
| ▸ | TLR2 | O60603 | 4/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.52 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.51 |
| ▸ | GLP1R | P43220 | 1/20 | 0.51 |
| ▸ | GCGR | P47871 | 1/20 | 0.51 |
| ▸ | GIPR | P48546 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728785 | 0.93 | IL23R (0.57) | KISS1RTLR2IL23RGLP1RGCGR | |
| SCHEMBL30108349 | 0.91 | KISS1R (0.55) | KISS1RTLR2ERAP2IL23R | |
| SCHEMBL29393516 | 0.91 | ERAP2 (0.56) | KISS1RERAP2 | |
| SCHEMBL29607306 | 0.91 | TLR2 (0.59) | KISS1RTLR2IL23RGLP1RGCGR | |
| SCHEMBL29970258 | 0.90 | GLP1R (0.63) | TLR2IL23RGLP1RGCGRGIPR | |
| SCHEMBL29608081 | 0.89 | GLP1R (0.62) | KISS1RTLR2IL23RGLP1RGCGR | |
| SCHEMBL31047373 | 0.88 | KISS1R (0.57) | KISS1RIL23R | |
| SCHEMBL30262138 | 0.88 | TLR2 (0.61) | TLR2GLP1RGCGRGIPR | |
| SCHEMBL32667969 | 0.87 | ERAP2 (0.60) | KISS1RERAP2 | |
| SCHEMBL31182787 | 0.85 | GLP1R (0.65) | KISS1RTLR2IL23RGLP1RGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | KISS1R 179/4885TLR2 483/4885ERAP2 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.